Medication info
Hanol Famotidine Tablet 20 mg

Hanol Famotidine Tablet 20 mg

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Hanol BioPharma Co., Ltd.
Appearance
Light green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200300306 · Notified 2003.11.19 · Insurance code 655603150

Summary

Main use
Treatment of acid-related disorders and upper gastrointestinal bleeding; suppression of gastric acid before anesthesia
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take famotidine 20 mg orally per dose twice daily (after breakfast and dinner or at bedtime), or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation and changed to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take famotidine 10 mg orally per dose twice daily (after breakfast and dinner or at bedtime), or 20 mg orally once daily (at bedtime). Adjust the dose as needed according to age and symptoms. (Injection) Adults: Dissolve 20 mg of famotidine per dose in 20 mL of normal saline or glucose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Change to oral administration once oral dosing is possible. For preanesthetic medication, dissolve 20 mg per dose in 1-1.5 mL of water for injection and administer by intramuscular injection 1 hour before induction of anesthesia, or dissolve in 20 mL of normal saline or glucose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or under refrigeration. Adjust the dose as needed according to age and symptoms.

Ingredients

Manufacturer
Hanol BioPharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders and upper gastrointestinal bleeding; suppression of gastric acid before anesthesia

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • mucosal erosion
  • mucosal bleeding
  • mucosal erythema
View approved original text

This medication is used as an oral and injectable form and is utilized for the treatment of gastric and duodenal ulcers, anastomotic ulcers, and related hemorrhagic diseases. It is also effective in treating gastroesophageal reflux disease and Zollinger-Ellison syndrome, and improves mucosal lesions associated with acute and chronic gastritis. The injectable form is particularly used for cases of upper gastrointestinal bleeding or pre-anesthetic administration, assisting in alleviating symptoms due to gastrointestinal diseases and promoting mucosal recovery. Overall, this medication is widely used in the treatment of gastrointestinal and digestive disorders.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take famotidine 20 mg orally per dose twice daily (after breakfast and dinner or at bedtime), or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation and changed to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take famotidine 10 mg orally per dose twice daily (after breakfast and dinner or at bedtime), or 20 mg orally once daily (at bedtime). Adjust the dose as needed according to age and symptoms. (Injection) Adults: Dissolve 20 mg of famotidine per dose in 20 mL of normal saline or glucose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Change to oral administration once oral dosing is possible. For preanesthetic medication, dissolve 20 mg per dose in 1-1.5 mL of water for injection and administer by intramuscular injection 1 hour before induction of anesthesia, or dissolve in 20 mL of normal saline or glucose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or under refrigeration. Adjust the dose as needed according to age and symptoms.

Precautions

This medication should not be used by individuals who are allergic to certain components or similar medications. It also contains lactose, so it should not be administered to patients with lactose intolerance or specific genetic metabolic disorders. Patients with a history of allergic reactions to this medication, kidney or liver dysfunction, heart conditions, and the elderly should use this medication with particular caution. While taking this medication, rare but serious allergic reactions, decrease in blood cell count, severe skin disorders, liver dysfunction, muscle damage, cardiac rhythm disturbances, consciousness disorders, kidney problems, and pulmonary diseases may occur, and patients should consult healthcare professionals immediately if symptoms arise. Common side effects include skin rash, indigestion, blood pressure changes, dizziness, drowsiness, and headaches; if these symptoms are severe, the use of the medication should be discontinued and medical advice sought. During treatment, regular blood tests and examinations of liver and kidney function should be conducted to closely monitor the condition. Patients undergoing hemodialysis should be cautious as the combination of this medication with certain phosphate binders may reduce effectiveness. The efficacy of this medication may decrease when taken with certain antifungals or chemotherapeutics, so patients must inform their doctor of all medications currently being taken. Elderly patients may have an increased risk of decreased kidney function, leading to elevated drug concentrations, and dosage adjustments may be necessary. Pregnant women or those who could become pregnant should only use this medication when the benefits outweigh the risks, and breastfeeding women are advised to stop breastfeeding. Safety in children has not been sufficiently established, so use in this population should be approached with caution. Lastly, this medication may mask symptoms of gastric cancer, so it should only be used after ensuring that gastric cancer is not present.

Side effects

  • shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized rash
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 86 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Lyell's syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized convulsions
  • rigidity
  • tonic convulsions
  • myoclonic convulsions
  • interstitial nephritis
  • acute renal failure
  • rash
  • urticaria
  • dyspnea
  • chest X-ray abnormalities
  • compromised contraction
  • rash
  • urticaria
  • erythema
  • facial edema
  • leukopenia
  • thrombocytopenia
  • eosinophilia
  • constipation
  • diarrhea
  • loose stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • heart block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucination
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • feeling of heaviness
  • reversible confusional state
  • depression
  • convulsions
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Light green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.